MEDIUM confidence: 100% data completeness, but the composite (58) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $16.1B— | $15.9B-1.1% | $18.4B+15.8% | $22.0B+19.9% | $22.8B+3.4% |
| EPS (dil.) | $9.04— | $7.64-15.5% | $13.44+75.9% | $10.73-20.2% | $17.69+64.9% |
| Free Cash Flow | $4.2B— | $1.3B-68.3% | $4.0B+206.8% | $9.4B+131.7% | $4.1B-56.3% |
| Gross Margin | 11.5% | 9.9%-1.7pp | 12.7%+2.8pp | 11.3%-1.4pp | 25.4%+14.1pp |
| Operating Margin | 8.6% | 4.5%-4.1pp | 6.3%+1.8pp | 4.4%-1.9pp | 6.8%+2.3pp |
| Net Margin | 7.3% | 3.3%-4.0pp | 4.9%+1.6pp | 3.3%-1.7pp | 5.2%+1.9pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth below the analyst consensus of 7.7%/yr (revenue basis).
Base free cash flow $5.8B (avg FY2023–FY2025; latest year $4.1B) · equity value $17.3B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Fewer than 3 analysts refreshed a price target in the last month, so no revision can be computed. Prior quarter: $284 avg across 6 analysts.
Buy-rated share 60% → 70% over ~3 months (+10pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $6.50 | $8.89 | +36.8% |
| May 2026 | $6.03 | $6.97 | +15.6% |
| Feb 2026 | $5.78 | $7.75 | +34.1% |
| Oct 2025 | $5.76 | $6.37 | +10.6% |
| Jul 2025 | $5.58 | $4.72 | -15.4% |
| May 2025 | $5.31 | $5.66 | +6.6% |
| Feb 2025 | $5.24 | $4.99 | -4.8% |
| Oct 2024 | $5.31 | $6.13 | +15.4% |
Net insider -$3.7M over 180 days (0 open-market buys, 4 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
The QScore of 58 for RGA indicates a moderately favorable outlook, driven by strong momentum and attractive valuation. The stock scores high on value, with a P/E of 11.5 and P/B of 1.3, and exhibits strong momentum, with a 12-month return of 39.6%. In contrast, profitability scores are relatively low, with an ROE of 11.3%. The short-term score of 61 diverges from the long-term score of 54, suggesting a recent uptrend, with the stock's 3-month return of 12.0% contributing to this difference.